Research Article
Tocilizumab Effect on Lipid Profile in Correlation to Cardiovascular Events: A Retrospective Cohort Study
Table 4
Clinical characteristics at baseline: lipid profile.
| | Tocilizumab | Control | Total | value |
| | Median (min, max) | HDL-C (mmol/L) | 1.5 (0.6, 2.45) | 1.7 (0.8, 5.0) | 1.5 (0.6, 5.2) | 0.93 | TRIG (mmol/L) | 1.0 (0.5, 5.9) | 1.0 (0.4, 5.0) | 1.0 (0.4, 5.9) | 0.58 | | | LDL-C (mmol/L) | | | | 0.84 | Total CHOL (mmol/L) | | | | 0.86 |
|
|